176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.43%
Revenue growth 1.25-1.5x MU's 8.25%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
14.79%
Gross profit growth above 1.5x MU's 9.06%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
19.89%
EBIT growth above 1.5x MU's 10.73%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
19.89%
Operating income growth above 1.5x MU's 10.73%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
33.41%
Net income growth above 1.5x MU's 13.13%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
31.43%
EPS growth above 1.5x MU's 13.03%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
36.36%
Diluted EPS growth above 1.5x MU's 14.84%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.50%
Share change of 0.50% while MU is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
7.80%
Dividend growth of 7.80% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
17.37%
OCF growth at 75-90% of MU's 20.98%. Bill Ackman would demand better working capital management or cost discipline.
-13.42%
Negative FCF growth while MU is at 56.46%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
121.65%
10Y revenue/share CAGR under 50% of MU's 288.38%. Michael Burry would suspect a lasting competitive disadvantage.
169.14%
5Y revenue/share CAGR similar to MU's 164.65%. Walter Schloss might see both companies benefiting from the same mid-term trends.
109.03%
3Y revenue/share CAGR similar to MU's 114.42%. Walter Schloss would assume both companies experience comparable short-term cycles.
392.59%
10Y OCF/share CAGR under 50% of MU's 1314.51%. Michael Burry would worry about a persistent underperformance in cash creation.
208.14%
Below 50% of MU's 540.93%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
175.44%
3Y OCF/share CAGR under 50% of MU's 357.73%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
298.40%
Below 50% of MU's 938.32%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
557.65%
5Y net income/share CAGR above 1.5x MU's 125.74%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
419.83%
3Y net income/share CAGR 50-75% of MU's 739.82%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
161.35%
10Y equity/share CAGR at 50-75% of MU's 248.54%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
58.37%
Below 50% of MU's 214.91%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
51.85%
Below 50% of MU's 140.09%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
98.71%
Dividend/share CAGR of 98.71% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
76.81%
3Y dividend/share CAGR of 76.81% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
8.40%
AR growth well above MU's 11.52%. Michael Burry fears inflated revenue or higher default risk in the near future.
-7.12%
Inventory is declining while MU stands at 6.71%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
14.35%
Asset growth above 1.5x MU's 3.66%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
17.03%
BV/share growth of 17.03% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-0.50%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
9.96%
We increase R&D while MU cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.77%
SG&A growth well above MU's 1.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.